Samsung Biologics Co Ltd
CUSIP: 00BYNJCV6
Samsung Biologics Co Ltd — institutional ownership and SEC 13F holdings data. Source: SEC EDGAR 13F filings.
About
Samsung Biologics is a South Korea–based contract development and manufacturing organization (CDMO) that provides development, analytical, and large-scale commercial manufacturing services for biologic drugs, including monoclonal antibodies and recombinant proteins. As an affiliate of the Samsung group, it operates multiple large biomanufacturing facilities in Songdo and serves global pharmaceutical and biotech clients with end-to-end process development, quality control, and sterile fill/finish capabilities, positioning it among the leading global CDMOs for biologics.
Institutional Holders
Source: SEC EDGAR 13F-HR filings from institutional investment managers.
Try asking...